We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost savings...
SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily...
SCOTTSDALE, Ariz., March 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on...
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the...
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea NDA submission supported by positive...
false 0001867066 0001867066 2023-12-27 2023-12-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.24 | -6.12244897959 | 3.92 | 4.3 | 2.85 | 362506 | 3.46313637 | CS |
4 | 0.03 | 0.821917808219 | 3.65 | 4.3 | 2.85 | 173440 | 3.55871729 | CS |
12 | -1.26 | -25.5060728745 | 4.94 | 5.77 | 2.85 | 182507 | 4.39491577 | CS |
26 | 0.97 | 35.7933579336 | 2.71 | 8.11 | 2.55 | 207301 | 5.21399652 | CS |
52 | 2.39 | 185.271317829 | 1.29 | 8.11 | 1.02 | 166893 | 4.03499057 | CS |
156 | -5.02 | -57.7011494253 | 8.7 | 10.2 | 1.02 | 95558 | 4.35374752 | CS |
260 | -9.32 | -71.6923076923 | 13 | 25.99 | 1.02 | 431111 | 11.44226068 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions